Photo Courtesy of: Lalaka/Shutterstock
Benzinga Money is a reader-supported publication. We may earn a commission from the advertisers associated with this article. Read our Advertiser Discloser.
Imagine this: You invest a modest $10,000 in a cutting-edge healthtech company, and just a few years later, you’re sitting on a small fortune. Sounds like a dream, right? Well, what if we told you that Health Care Originals (HCO), a company revolutionizing the $83 billion respiratory care market, might be your next big opportunity?
How much could you have made if you had spotted this early? And is it still worth getting in now?
What is Health Care Originals (HCO)?
Founded to tackle one of the world’s biggest health concerns, HCO is a venture-backed healthtech company that specializes in AI-powered, non-invasive wearable technology. Their flagship Nightingale Virtual Respiratory Care program is already transforming asthma and COPD treatment, a market that affects millions worldwide.
Some eye-opening stats:
- $5.5M in contracted annual recurring revenue (ARR)
- 1,000+ patients treated
- 12,000+ on the waitlist (massive demand!)
- Clinically proven results: 2 out of 3 users reported zero asthma attacks or COPD flare-ups in six months
Backed by Safar Partners, Kingscrowd Capital, D3VC.ai and Chloe Capital, HCO is scaling fast to meet growing demand. The company is raising funds on Wefunder and both accredited and non-accredited investors can get in with as little as $100.
But what if you had invested earlier? Let’s see how much you could have made.
The Hypothetical Investment: $10,000 in HCO
Let’s say you had invested $10K when HCO was valued at just $5 million (a realistic estimate based on past early-stage raises). With an early-stage share price around $1.00, you would have bagged 10,000 shares.
Fast forward to today: HCO’s current pre-money valuation is $13 million. That means:
💰 Your $10K investment would now be worth $26K!
🔥 A 160% return in just a short period.
And if HCO continues its growth trajectory, early investors could be looking at 10X or even 20X returns down the road.
The Future of HCO: Can It Keep Growing?
Experts in the healthtech sector believe that AI-driven healthcare solutions will dominate the next decade. The wearable tech market alone is projected to hit $265 billion by 2031.
Here’s why HCO might be positioned to explode even further:
- Massive, untapped market: Millions suffer from chronic respiratory conditions
- AI & predictive health monitoring are the future of care
- Recurring revenue model: Long-term patient retention = reliable cash flow
- Strong backing from top venture funds
- A platform technology with use cases beyond just respiratory
- The company intends to move into cardiology next
If HCO keeps up its growth rate, its valuation could hit $100 million+ in the coming years. A 10X return isn’t out of the question.
How to Invest Before It’s Too Late
It’s rare to find a high-growth, AI-powered healthtech startup that’s still accessible to everyday investors. Right now, HCO is raising on Wefunder, allowing investors to get in at just $1.52 per share (view their campaign page to check full terms and conditions). HCO is also the first platform to offer warrants on Wefunder, which means investors get warrants with each share purchased and the warrants convert into preferred shares.
Invest in HCO Now on Wefunder.
Disclaimers:
Please be advised that alternative investments carry a risk of monetary loss. Neither Benzinga nor its staff recommends that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. All information contained on this website is provided as general commentary for informative and entertainment purposes and does not constitute investment advice.
Benzinga will not accept liability for any loss or damage, including without limitation to, any loss of profit, which may arise directly or indirectly from use of or reliance on this information, whether specifically stated in the above Terms of Service or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
